首页 | 本学科首页   官方微博 | 高级检索  
     

白脂素与2型糖尿病及其血管并发症的研究进展
引用本文:沙宇菁,李彦彦,杨玲. 白脂素与2型糖尿病及其血管并发症的研究进展[J]. 国际内分泌代谢杂志, 2021, 41(2): 133-137
作者姓名:沙宇菁  李彦彦  杨玲
作者单位:江苏大学附属医院内分泌代谢科,镇江 212000
基金项目:江苏省预防医学科研课题(Y2018109)。
摘    要:白脂素(asprosin)是一种新型葡萄糖调控蛋白激素,其主要由白色脂肪细胞合成分泌。Asprosin可通过增强胰岛素抵抗、调节胰岛素分泌、影响食欲参与糖脂代谢,从而调节血糖稳态。此外,研究发现Asprosin与糖尿病大血管并发症及糖尿病微血管并发症存在较多联系,但具体机制尚不清楚。深入探讨Asprosin与糖尿病及其...

关 键 词:白脂素  2型糖尿病  糖尿病大血管并发症  糖尿病微血管并发症

Research progress of asprosin in type 2 diabetes mellitus and its vascular complications
Sha Yujing,Li Yanyan,Yang Ling. Research progress of asprosin in type 2 diabetes mellitus and its vascular complications[J]. International JOurnal of Endocrinology and Metabolism, 2021, 41(2): 133-137
Authors:Sha Yujing  Li Yanyan  Yang Ling
Affiliation:(Department of Endocrinology,Affiliated Hospital of Jiangsu University,Zhenjiang 212000,China)
Abstract:Asprosin is a new type of glucose regulatory protein hormone,which is mainly synthesized and secreted by white adipocytes.Asprosin can regulate glucose homeostasis by enhancing insulin resistance,regulating insulin secretion and affecting appetite.In addition,studies have found that asprosin is associated with diabetic macrovascular complications and diabetic microvascular complications,but the specific mechanism is not clear.In order to provide a new target for the treatment of diabetes mellitus and its vascular complications,the mechanism of asprosin in diabetes mellitus and its vascular complications should be explored.
Keywords:Asprosin  Type 2 diabetes  Diabetic macrovascular diseases  Diabetic microvascular diseases
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号